IRADIMED CORP
For the period ended Dec 31, 2023. Filed Mar 1, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 1, 2024
IRMD$86.94+0.7%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
INDEX TO FINANCIAL STATEMENTS
| | | |
|---|---|---|
| Report of Independent Registered Public Accounting Firm (PCAOB ID: 49) | F-2 | |
| Balance Sheets | | F-4 |
| Statements of Operations | | F-5 |
| Statements of Comprehensive Income | | F-6 |
| Statements of Stockholders’ Equity | | F-7 |
| Statements of Cash Flows | | F-8 |
| Notes to Financial Statements | | F-9 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.